NCCN task force report: positron emission tomography (PET)/computed tomography (CT) scanning in cancer.
about
Is cancer a metabolic disease?Impact of (18)F-FDG PET/CT on the staging and management of follicular lymphoma.Positron Emission Tomography (PET) in OncologyThe lack of evidence for PET or PET/CT surveillance of patients with treated lymphoma, colorectal cancer, and head and neck cancer: a systematic review.PET/CT without capacity limitations: a Danish experience from a European perspective.The role of 18F-FDG-PET/CT in the preoperative staging and posttherapy follow up of gastric cancer: comparison with spiral CTThe emergence of diagnostic imaging technologies in breast cancer: discovery, regulatory approval, reimbursement, and adoption in clinical guidelinesPositron Emission Tomography (PET) in Oncology: A Systematic Review of Clinical Effectiveness and Indications for Use.Nodular sclerosing Hodgkin's lymphoma presenting with a pseudo-breast mass extending from a necrotizing granulomatous mediastinal tumor.Non-Hodgkin's lymphoma of the testicle and bilateral adrenals detected by (18)F-FDG PET/CT.Predictors of pathologic outcome of focal FDG uptake in the parotid gland identified on whole-body FDG PET imaging.Shifting trends in liver-directed management of patients with colorectal liver metastasis: a population-based analysis.False Positive 18F-FDG Uptake in Mediastinal Lymph Nodes Detected with Positron Emission Tomography in Breast Cancer: A Case Report.Geographic and sociodemographic disparities in PET use by Medicare beneficiaries with cancer.Sarcoma mid-therapy [F-18]fluorodeoxyglucose positron emission tomography (FDG PET) and patient outcome68Ga-PSMA-HBED-CC PET imaging in breast carcinoma patients.The Impact of Social Contagion on Physician Adoption of Advanced Imaging Tests in Breast Cancer.
P2860
Q26852241-3C21E549-7E34-4535-A8D4-D2950163D882Q34223214-DC3CF1D5-77BC-445A-8522-3CF755E516B4Q34774840-FDACA850-9295-4EC5-A888-36D97ED0E213Q34775441-C3955B8A-B9C6-4923-AC9B-9A66C7CDC820Q34940350-CD965803-D89E-4C74-8014-B44D22F1DC7EQ35143763-0533EA27-ED16-4EA7-8565-E98BE7F77F7FQ35697644-0569642B-BA3F-4C09-9B7A-E3500106F7C1Q36137806-CD2C370D-0E9D-47D3-A80C-353717A8CC88Q36166362-17D11E47-7C2F-42F6-BB8D-99EEE4B00C34Q36230884-E3C85865-3FCA-4869-A9D8-F26C243B3931Q36240590-42ED4434-C343-4688-89E5-52657B4098BFQ36598926-9F263BE0-CEC8-45D2-BAFA-6CD5C3C3478FQ36702891-90CE7A1A-A081-4AE1-BDBA-2453824E69DFQ37316598-A40B6CC5-E158-4228-819C-A2765225ACD7Q37519308-94B4B6E6-3908-453E-A7D3-F7FFFD2E4EBBQ37662685-FDCBF5FB-DEF0-4F72-9435-ECEE3EAB8B74Q40258697-397AAC87-81A1-41FC-969F-1F7FF0FCD122
P2860
NCCN task force report: positron emission tomography (PET)/computed tomography (CT) scanning in cancer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
NCCN task force report: positr ...... raphy (CT) scanning in cancer.
@en
type
label
NCCN task force report: positr ...... raphy (CT) scanning in cancer.
@en
prefLabel
NCCN task force report: positr ...... raphy (CT) scanning in cancer.
@en
P2093
P1476
NCCN task force report: positr ...... graphy (CT) scanning in cancer
@en
P2093
Al B Benson
Bruce E Hillner
Craig Allred
David A Mankoff
David S Ettinger
Dominique Delbeke
Donald A Podoloff
Elizabeth Brown
Frederic W Grannis
Harold J Burstein
P304
S1-22; quiz S23-2
P478
P577
2007-05-01T00:00:00Z